1. Home
  2. CRDO vs IQV Comparison

CRDO vs IQV Comparison

Compare CRDO & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$148.52

Market Cap

34.2B

Sector

Technology

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$225.09

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDO
IQV
Founded
2008
1982
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
36.4B
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
CRDO
IQV
Price
$148.52
$225.09
Analyst Decision
Strong Buy
Buy
Analyst Count
12
15
Target Price
$179.91
$236.93
AVG Volume (30 Days)
7.4M
1.5M
Earning Date
12-01-2025
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.11
7.30
Revenue
$796,128,000.00
$15,904,000,000.00
Revenue This Year
$127.02
$6.14
Revenue Next Year
$28.18
$5.35
P/E Ratio
$134.88
$30.72
Revenue Growth
224.17
3.85
52 Week Low
$29.09
$134.65
52 Week High
$213.80
$234.30

Technical Indicators

Market Signals
Indicator
CRDO
IQV
Relative Strength Index (RSI) 46.26 54.97
Support Level $132.76 $219.91
Resistance Level $156.09 $225.80
Average True Range (ATR) 9.87 5.04
MACD -1.88 -0.55
Stochastic Oscillator 28.08 81.40

Price Performance

Historical Comparison
CRDO
IQV

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Share on Social Networks: